Manchester Royal Eye Hospital is the second largest Eye Hospital in the UK and covers a broad research portfolio from laboratory studies through to the development of new technology, diagnostics and treatments.
There is a strong ophthalmic genetics unit, with longstanding research into vitreous biochemistry and particular strengths in glaucoma research. The Manchester Royal Eye Hospital’s device portfolio includes clinical trials of the ‘bionic eye’ implant [Link to Keith patient story].
